EcoDrugPlus

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSCHOG00000004225
Gene Symbol: FDFT1
1 Cross references
218 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSCHOG00000009284
Gene Symbol: FNTA
1 Cross references
222 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSCHOG00000008241
Gene Symbol: FNTB
1 Cross references
211 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSCHOG00000013812
Gene Symbol: FAP
1 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSCHOG00000011370
Gene Symbol: FGF2
1 Cross references
119 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSCHOG00000003406
Gene Symbol: FGFR2
1 Cross references
218 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSCHOG00000006767
Gene Symbol: FLT1
1 Cross references
199 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSCHOG00000013520
Gene Symbol: FLT3
1 Cross references
134 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSCHOG00000011849
Gene Symbol: FOLR1
1 Cross references
203 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSCHOG00000004782
Gene Symbol: FSHR
1 Cross references
200 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSCHOG00000003144
Gene Symbol: FRK
1 Cross references
217 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSCHOG00000010267
Gene Symbol: GLA
1 Cross references
197 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).